| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 03/01/2005 | US6861238 Retinoid metabolizing protein |
| 03/01/2005 | US6861055 Human GDP-mannose 4,6-dehydratase |
| 03/01/2005 | CA2237120C Compositions and methods for producing heterologous polypeptides in pichia methanolica |
| 03/01/2005 | CA2114631C N-acetylglucosaminyltransferase v coding sequences |
| 02/24/2005 | WO2005017174A2 Process for the purification of recombinant polypeptides |
| 02/24/2005 | WO2005017172A1 Microbial production of l-ascorbic acid |
| 02/24/2005 | WO2005017166A1 Method for the production of a lysate used for cell-free protein biosynthesis |
| 02/24/2005 | WO2005017159A2 Microbial production of l-ascorbic acid |
| 02/24/2005 | WO2005017141A1 Improved halohydrin dehalogenases and related polynucleotides |
| 02/24/2005 | WO2005017136A1 Methods and compositions for determination of glycated proteins |
| 02/24/2005 | WO2005017099A2 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters |
| 02/24/2005 | WO2005017095A2 A stable liquid probiotic composition, preparation and applications thereof |
| 02/24/2005 | WO2005016960A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 02/24/2005 | WO2005016950A1 Methods for humanizing rabbit monoclonal antibodies |
| 02/24/2005 | WO2005016024A1 Method for dissociation of cells |
| 02/24/2005 | WO2004111218A3 Method for producing glucoamylases and their uses |
| 02/24/2005 | WO2004108905A3 Hygienic consolidation of a multi-chamber dosing spray technique and the probiotic use thereof for the application of viable micro-organisms |
| 02/24/2005 | WO2004056973A3 Method for chromosomal engineering |
| 02/24/2005 | WO2004050684A3 Methods for improving secondary metabolite production in fungi |
| 02/24/2005 | WO2004016220A3 Apicomplexan pathways, inhibitiors, and drug delivery |
| 02/24/2005 | WO2003083043A3 Methods for producing secreted polypeptides having l-asparaginase activity |
| 02/24/2005 | WO2003062381A3 Multiply-substituted protease variants |
| 02/24/2005 | WO2003053921A3 Mutant proteinase inhibitors and uses thereof |
| 02/24/2005 | WO2003018758A3 Reagents and methods for smooth muscle therapies |
| 02/24/2005 | WO2001000643A3 Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase |
| 02/24/2005 | US20050043528 Enterococcus faecalis polynucleotides and polypeptides |
| 02/24/2005 | US20050043526 Sigma factor A (SIGA) protein for use as tool in expression of operons associated with lysine biosynthesis; ennhancing animal feeds; cosmetics; medicine |
| 02/24/2005 | US20050043519 Generating immunoglobulin specific to novel antigen receptor (NAR) for use in innunodiagnostic and immunotherapy |
| 02/24/2005 | US20050043512 Human glioma antigen originating in testis |
| 02/24/2005 | US20050043511 G-protein coupled receptor lustr2 and uses thereof |
| 02/24/2005 | US20050043252 Pesticidal macrolides |
| 02/24/2005 | US20050043241 Use of inhibitors of given amino acid sequence; inhibit phosphorylation of a transcription factor; can be used to treat or prevent diabetes, ionizing radiation damage, autoimmune diseases, ischemia/reperfusion injuries, heart hypertrophies, cancer |
| 02/24/2005 | US20050043198 A related nucleic acid, expression vector, host cell, and protein, the protein having a common epitope with the protease; the protease acts as an unspecific endopeptidase; cleaners also contain an amylase, cellulase, hemicellulase, oxidoreductase, or lipase; cosmetics |
| 02/24/2005 | US20050042756 Intergenic and intragenic integration sites for foreign gene expression in recombinant S. gordonii strains |
| 02/24/2005 | US20050042755 Bacterium for use as vehicle for gene transport and transfer to preferential organs or tissues; tissue engineering and targeted somatic transgenesis |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042735 Metabolic engineering for enhanced production of chitin and chitosan in microorganisms |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042728 Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof |
| 02/24/2005 | US20050042727 UDP-N-acetylglucosamine: galactose-Beta 1,3-N-A-acetylgalactosamine-alpha-R/N-acetylglucosamine-Beta 1,3-N-acetylgalactosamine-alpha-R (GIcNAc to GalNac) Beta 1,6-N-acetylglucosaminyltransferase, C2/4GnT |
| 02/24/2005 | US20050042724 Sodium-dependent phosphate cotransporter (NAPTR) for use tool in identifying modulators for treatment and prevention of cell proliferative, nervous system and cardiovascular disorders |
| 02/24/2005 | US20050042718 Using transgenic cells to generate monoclonal antibodies for use in immunodiagnostics and tissue directed therapy |
| 02/24/2005 | US20050042717 Scorpion toxins |
| 02/24/2005 | US20050042706 Methods for the identification of inhibitors of porphobilinogen deaminase as antibiotics |
| 02/24/2005 | US20050042680 Single chain antigen-binding polypeptides for polymer conjugation |
| 02/24/2005 | US20050042667 Expression vector comprising nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of immune, hematopoietic, inflammatory and tumor diseases |
| 02/24/2005 | US20050042661 Quaternary ammonium compounds for rapidly distinguishing cellular components |
| 02/24/2005 | US20050042655 Using hematopoietoic regulatory related polypeptide (HEMA) for use in diagnosis, treatment and prevention of hematopoietic disorders |
| 02/24/2005 | US20050042653 Human transport protein homologs |
| 02/24/2005 | US20050042594 Frozen or freeze-dried culture for use in preparation of cheese and butermilk |
| 02/24/2005 | US20050042328 Culture product; yeast extracts; for food, beverages |
| 02/24/2005 | US20050042327 Methods and compositions for increasing fermentation of a microorganism |
| 02/24/2005 | US20050042231 Useful in vaccines, and monoclonal antibodies against said immunogenic surface proteins; hybridoma cell line that produes said antibodies; use in diagnostic kits for determining presence, onset, or decrease in Leptospiral infection |
| 02/24/2005 | US20050042222 Methods of diagnosing thyroid carcinoma |
| 02/24/2005 | US20050042216 Binding monoclonal, humanized, or fragment of antibody to human cell that expresses a protein; cancer |
| 02/24/2005 | US20050042207 Escherichia bacteria; diarrhea, autoimmune diseases, microbial infections, irritable bowel syndrome, and inflammatory bowel disease; side effect reduction |
| 02/24/2005 | US20050042201 Synergistic mixture of glycoprotein and angiogenesis inhibitor comprising angiostatin, thrombostatin, endostatin, interferon, interferon-inducible factor 10, platelet factor, and/or cyclooxygenase inhibitor; antitumor and anticarcinogenic agents |
| 02/24/2005 | DE102004028859A1 Preparing L-threonine by culturing bacteria of Enterobacteriaceae family in nutrient medium comprising source of carbon, nitrogen and phosphorus, to produce L-threonine |
| 02/24/2005 | CA2852159A1 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters |
| 02/24/2005 | CA2535892A1 A stable liquid probiotic composition, preparation and applications thereof |
| 02/24/2005 | CA2535670A1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 02/24/2005 | CA2535255A1 Improved halohydrin dehalogenases and related polynucleotides |
| 02/24/2005 | CA2533830A1 Methods for humanizing rabbit monoclonal antibodies |
| 02/24/2005 | CA2532557A1 Methods and compositions for determination of glycated proteins |
| 02/24/2005 | CA2526595A1 Metabolically engineered bacterial strains having non-functional endogenous gluconate transporters |
| 02/23/2005 | EP1508620A1 Circular DNA molecule with conditional origin of replication, method for preparing same and use thereof in gene therapy |
| 02/23/2005 | EP1508619A1 Novel promoter |
| 02/23/2005 | EP1508614A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 02/23/2005 | EP1508339A1 Tuberculosis vaccine |
| 02/23/2005 | EP1508047A2 Method for identifying immunoreactive peptides |
| 02/23/2005 | EP1507870A2 Enzymes having dehalogenase activity and methods of use thereof |
| 02/23/2005 | EP1507866A2 Carotene synthase gene and uses therefor |
| 02/23/2005 | EP1507863A1 Plasmid stabilisation in vivo |
| 02/23/2005 | EP1507862A2 Modified tetracycline repressor protein compositions and methods of use |
| 02/23/2005 | EP1507855A2 Elongase genes and uses thereof |
| 02/23/2005 | EP1507802A1 Transformed fungi for production of recombinant proteins |
| 02/23/2005 | EP1507790A2 Human genes and gene expression products isolated from human prostate |
| 02/23/2005 | EP0946233B1 Method of gasifying or degasifying a liquid |
| 02/23/2005 | CN1585823A Genes coding for DNA replication proteins and for proteins related to pathogenesis |
| 02/23/2005 | CN1585822A Polycistronic expression of antibodies |
| 02/23/2005 | CN1585776A Detection and identification of enteric bacteria |
| 02/23/2005 | CN1584035A Expressions of recombined swine lactoferrin and its peptide by pichia |
| 02/23/2005 | CN1584026A Production of oligomeric xylose and special immobilized xylanase therefor |
| 02/23/2005 | CN1584019A Moderate holophilic bacteria for degradation of phenylacetic acid and bacteria agent therefrom |
| 02/23/2005 | CN1584018A Triazine herbicide residual degrading strain and strain therefrom |
| 02/23/2005 | CN1584017A Triazoline pesticide residual degrading strain and strain therefrom |
| 02/23/2005 | CN1584016A Amycolatosis and biological conversion of lovastatin into wuxistatin thereby |
| 02/23/2005 | CN1584015A Preparation of valuable sialinic acid from cheap sodium lactate by multi-step coupling bio-conversion |
| 02/23/2005 | CN1584014A Acinetobacter for denitrification and decomposing ammonia in wastewater |
| 02/23/2005 | CN1584013A Composite cultural media for fermentation of bifidobacteruim and its preparation |
| 02/23/2005 | CN1584012A Membrane culturing method for fibrillar strain solid culturing research |
| 02/23/2005 | CN1584011A Spirulina containing arginine, ornithine or citrulline |
| 02/23/2005 | CN1584010A Process for producing Sporidiobolus ruineniae strains with improved coenzyme Q10 production |
| 02/23/2005 | CN1584009A Fermenting liquid for feed with microbiological colonies |
| 02/23/2005 | CN1583676A Manufacturing method for microbial manure for subtropical forest sprouts |
| 02/23/2005 | CN1582956A Composition of mycobacterium polysaccharide and its preparation |
| 02/23/2005 | CN1190497C Preparation technology of geldananycin |
| 02/23/2005 | CN1190495C Method for producing heterologous polypeptides in trichothecene-deficient filamentous fungal nutant cells |
| 02/23/2005 | CN1190491C PRV-gene and use thereof |
| 02/23/2005 | CN1190489C Pseudomonads and its preparation method and application |